Summary
22.22 -0.24(-1.05%)05/17/2024
Silk Road Medical Inc (SILK)
Silk Road Medical Inc (SILK)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -1.39 | 6.02 | 17.56 | 27.85 | 146.00 | -52.06 | -48.65 | -43.09 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 20.59 | |
| Open | 20.96 | |
| High | 21.24 | |
| Low | 20.17 | |
| Volume | 345,969 | |
| Change | -0.29 | |
| Change % | -1.39 | |
| Avg Volume (20 Days) | 474,309 | |
| Volume/Avg Volume (20 Days) Ratio | 0.73 | |
| 52 Week Range | 6.08 - 43.52 | |
| Price vs 52 Week High | -52.69% | |
| Price vs 52 Week Low | 238.65% | |
| Range | -1.77 | |
| Gap Up/Down | -0.24 | |
Fundamentals | ||
| Market Capitalization (Mln) | 878 | |
| EBIDTA | -24,408,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 62.33 | |
| Book Value | 2.5300 | |
| Earnings Per Share | -1.5070 | |
| EPS Estimate Current Quarter | -0.3000 | |
| EPS Estimate Next Quarter | -0.2700 | |
| EPS Estimate Current Year | -1.3500 | |
| EPS Estimate Next Year | -1.0000 | |
| Diluted EPS (TTM) | -1.5070 | |
| Revenues | ||
| Profit Marging | -0.5499 | |
| Operating Marging (TTM) | -0.5109 | |
| Return on asset (TTM) | -0.1725 | |
| Return on equity (TTM) | -0.4990 | |
| Revenue TTM | 94,344,000 | |
| Revenue per share TTM | 2.7410 | |
| Quarterly Revenue Growth (YOY) | 0.2310 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 53,936,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 16.3759 | |
| Revenue Enterprise Value | 14.5309 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 34,896,400 | |
| Shares Float | 34,077,041 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 2.59 | |
| Institutions (%) | 108.77 | |
04/30 20:05 EST - seekingalpha.com
Silk Road Medical, Inc (SILK) Q1 2024 Earnings Call Transcript
Silk Road Medical, Inc (NASDAQ:SILK ) Q1 2024 Results Conference Call April 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR Chas McKhann - Chief Executive Officer Lucas Buchanan - CFO and COO Conference Call Participants Rohin Patel - JPMorgan Rick Wise - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to Silk Road Medical's 2024 First Quarter Earnings Conference Call.
Silk Road Medical, Inc (SILK) Q1 2024 Earnings Call Transcript
Silk Road Medical, Inc (NASDAQ:SILK ) Q1 2024 Results Conference Call April 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR Chas McKhann - Chief Executive Officer Lucas Buchanan - CFO and COO Conference Call Participants Rohin Patel - JPMorgan Rick Wise - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to Silk Road Medical's 2024 First Quarter Earnings Conference Call.
04/30 16:05 EST - globenewswire.com
Silk Road Medical Reports First Quarter 2024 Financial Results
SUNNYVALE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2024.
Silk Road Medical Reports First Quarter 2024 Financial Results
SUNNYVALE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2024.
04/23 16:30 EST - globenewswire.com
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2024 Healthcare Conference.
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2024 Healthcare Conference.
04/23 13:00 EST - zacks.com
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
Silk Road Medical (SILK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
Silk Road Medical (SILK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
04/09 16:30 EST - globenewswire.com
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, April 30th, 2024. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, April 30th, 2024. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
04/08 11:25 EST - zacks.com
Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.
Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.
04/02 16:30 EST - globenewswire.com
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE ® Transcarotid Neuroprotection System PLUS (“NPS PLUS”), a key component of the TCAR® portfolio. This next generation device builds upon the prior ENROUTE Transcarotid Neuroprotection System to deliver smoother arterial sheath insertion, greater flow precision, and a simplified prep experience for surgical teams, all while maintaining unparalleled neuroprotection during the TCAR procedure.
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE ® Transcarotid Neuroprotection System PLUS (“NPS PLUS”), a key component of the TCAR® portfolio. This next generation device builds upon the prior ENROUTE Transcarotid Neuroprotection System to deliver smoother arterial sheath insertion, greater flow precision, and a simplified prep experience for surgical teams, all while maintaining unparalleled neuroprotection during the TCAR procedure.
03/22 13:01 EST - zacks.com
Silk Road Medical (SILK) Upgraded to Buy: What Does It Mean for the Stock?
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Silk Road Medical (SILK) Upgraded to Buy: What Does It Mean for the Stock?
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
03/07 08:56 EST - zacks.com
Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio
Silk Road Medical (SILK) announces the launch of its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.
Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio
Silk Road Medical (SILK) announces the launch of its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.
03/05 09:00 EST - globenewswire.com
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch expands upon the company's prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy. TCAR is a minimally invasive, surgical procedure designed to provide best-in-class stroke protection while minimizing adverse events.
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch expands upon the company's prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy. TCAR is a minimally invasive, surgical procedure designed to provide best-in-class stroke protection while minimizing adverse events.
02/28 23:24 EST - seekingalpha.com
Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript
Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript
Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript
Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript
02/28 19:21 EST - zacks.com
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.34 per share a year ago.
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.34 per share a year ago.
02/28 16:05 EST - globenewswire.com
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.
02/07 16:30 EST - globenewswire.com
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Wednesday, February 28th, 2024. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Wednesday, February 28th, 2024. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
01/22 08:31 EST - zacks.com
Silk Road Medical (SILK) Stock Jumps 12.7%: Will It Continue to Soar?
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Silk Road Medical (SILK) Stock Jumps 12.7%: Will It Continue to Soar?
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
12/20 16:30 EST - GlobeNewsWire
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
11/09 00:37 EST - seekingalpha.com
Silk Road Medical, Inc (SILK) Q3 2023 Earnings Call Transcript
Silk Road Medical, Inc (NASDAQ:SILK ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Director, Investor Relations Jack Lasersohn - Chairman Chas McKhann - Chief Executive Officer Lucas Buchanan - Chief Financial Officer and COO Conference Call Participants John McAulay - Stifel Rohin Patel - JPMorgan Adam Maeder - Piper Sandler Kristen Stewart - CL King Suraj Khalia - Oppenheimer & Company Michael Polark - Wolfe Research Operator Good day and thank you for standing by. Welcome to the Silk Road Medical Third Quarter 2023 Conference Call.
Silk Road Medical, Inc (SILK) Q3 2023 Earnings Call Transcript
Silk Road Medical, Inc (NASDAQ:SILK ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Director, Investor Relations Jack Lasersohn - Chairman Chas McKhann - Chief Executive Officer Lucas Buchanan - Chief Financial Officer and COO Conference Call Participants John McAulay - Stifel Rohin Patel - JPMorgan Adam Maeder - Piper Sandler Kristen Stewart - CL King Suraj Khalia - Oppenheimer & Company Michael Polark - Wolfe Research Operator Good day and thank you for standing by. Welcome to the Silk Road Medical Third Quarter 2023 Conference Call.
11/08 16:05 EST - globenewswire.com
Silk Road Medical Reports Third Quarter 2023 Financial Results
SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2023.
Silk Road Medical Reports Third Quarter 2023 Financial Results
SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2023.
11/03 18:31 EST - prnewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised to contact Robert S.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised to contact Robert S.
11/01 11:19 EST - zacks.com
Analysts Estimate Silk Road Medical (SILK) to Report a Decline in Earnings: What to Look Out for
Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Silk Road Medical (SILK) to Report a Decline in Earnings: What to Look Out for
Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.